Pentraxin Therapeutics Ltd is a University College London spin out company founded in 2001 by Professor Sir Mark Pepys FRS.  In September 2011 Sir Mark retired as head of medicine at the Royal Free Campus of UCL and became the first Director of the new UCL Wolfson Drug Discovery Unit, which he created with funding from the Wolfson Foundation.  Since 2012 the core funding of the Unit has been provided by the NIHR via its UCL/UCLH Biomedical Research Centre.  Pentraxin holds the intellectual property and proprietary knowledge created by Sir Mark and his research group.